Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News’ Nightline.
Peter Hotez, M.D., Ph.D.
Dr. Hotez is the founding dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, Texas, as well as director of the Texas Children’s Hospital Center for Vaccine Development, in addition to other prestigious academic posts he holds. He has authored hundreds of peer-reviewed articles and editorials as well as books, including “Vaccines Did Not Cause Rachel’s Autism: My Journey as a Vaccine Scientist, Pediatrician, and Autism Dad.”
Kumar is Vice President, Innovation, Global Health and Science Policy Communication at Johnson & Johnson and a world-renowned champion of the value of science and science journalism. Kumar drives public engagement and trust in science through development of storytelling initiatives and programs that create positive societal impact.
Having spent two decades at the nexus of science, policy and business, in January 2020 Dr. Parikh became the 19th Chief Executive Officer of the American Association for the Advancement of Science and Executive Publisher of the Science family of journals. An active member of the scientific advocacy community, Dr. Parikh serves as a board member and officer for several impactful organizations, including Research!America, Friends of Cancer Research and ACT for NIH.
Dr. Piot is the Director of the London School of Hygiene & Tropical Medicine and a Handa Professor of Global Health. In 1976, he co-discovered the Ebola virus. The prestigious posts he’s held include founding Executive Director of UNAIDS, Under Secretary-General of the United Nations, President of the International AIDS Society and Chair of the WHO Ebola Science Committee.
Woolley is the President and CEO of Research!America, the nation’s largest not-for-profit grassroots public education and advocacy organization committed to making medical and health research a higher national priority. Woolley is a longtime leader of advocacy for science, especially medical and health science. She’s also a high-profile speaker, writer and promoter of public engagement by scientists.
With its global Phase 3 clinical trial now fully enrolled with approximately 45,000 adult participants, we share the most up-to-date information about the single-dose investigational vaccine candidate.